Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 inhibitor, Mesutoclax (ICP-248), were presented at the 67th Annual Meeting of the American Society of Hematology (ASH). Mesutoclax demonstrated remarkable efficacy and a favorable safety profile in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and acute myeloid leukemia (AML).
ALT5 Sigma Corp INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALTS)NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against ALT5 Sigma Corp (“ALT5” or the “Company”) (
NASDAQ:ALTS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the FirmNEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DexCom, Inc. (
NASDAQ:DXCM) and CarMax, Inc. (
NYSE:KMX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
FISERV CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Fiserv, Inc. Investors to Contact the Firm Regarding Their RightsBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FI) To Contact Him Directly To Discuss Their Options
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible NotesNEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- IREN Limited (
NASDAQ: IREN) (“IREN”) today announced the closing of its offering of convertible senior notes and repurchase of certain existing convertible notes.
Interfor Announces Appointment of Chief Financial Officer; Chief Operating OfficerBURNABY, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it has made several leadership changes. Mike Mackay has been appointed Executive Vice President & Chief Financial Officer, effective December 8, 2025. Mr. Mackay, who joined Interfor in 2015, has held several leadership roles in the Company’s finance organization, most recently serving as Vice President, Corporate Development & Treasury. Mr. Mackay will succeed Rick Pozzebon, who will be leaving Interfor to pursue other opportunities.
Aeroméxico November 2025 Traffic ResultsMEXICO CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its November 2025 operational results:
Toll Brothers Reports FY 2025 Fourth Quarter ResultsFORT WASHINGTON, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (
NYSE:TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced results for its fourth quarter ended October 31, 2025.
Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron LaunchLONG BEACH, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the Neutron launch vehicle’s innovative “Hungry Hippo” captive fairing has successfully completed qualification testing and is enroute to Virginia for Neutron’s first launch.
ONEOK to Participate in Investor ConferenceTULSA, Okla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- ONEOK, Inc. (
NYSE: OKE) will participate in an investor conference this week and in a fireside chat session at 2:15 p.m. Eastern Time (1:15 p.m. Central Time) on Tuesday, Dec. 9.
Latham Group Appoints Sean Gadd as Chief Executive OfficerLATHAM, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, appoints Sean Gadd as the company’s new President and Chief Executive Officer as part of a CEO transition that will take effect on January 5, 2026. The appointment follows a comprehensive search as part of a succession planning process led by the Board and current CEO Scott Rajeski, who will be retiring from Latham and will serve as a special advisor to the company.
Orion Group Holdings to Participate in the Roth Capital Partners 14th Annual Deer Valley EventHOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (
NYSE: ORN) (the “Company”), a leading specialty construction company, today announced that Orion management will participate in the Roth Capital Partners 14th Annual Deer Valley Event. Management will participate in one-on-one meetings on Thursday, December 11, 2025.
Comscore Releases 2025 AI Intelligence Report: Establishing New Benchmarks for Generative AI Adoption and InfluenceNew Comscore analysis measures and analyzes AI usage, surfacing how the adoption of AI is changing the ways that consumers search, discover, and purchase
Paramount Gold Nevada Receives Draft Consolidated Permit Package From the State of Oregon for the Grassy Mountain Gold ProjectWINNEMUCCA, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announces today that The Oregon Department of Geology and Mineral Industries (“DOGAMI”) has published the draft consolidated permit package for the Grassy Mountain Gold Project on behalf of all state permitting and cooperating agencies.
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025LONDON and GAITHERSBURG, Md., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces presentation of preliminary data from the ongoing Phase 1 CARLYSLE trial in patients with severe refractory systemic lupus erythematosus (srSLE) in an oral presentation at the American Society of Hematology (ASH) Annual Meeting.
Reed’s, Inc. Announces Closing of $10 Million Public Offering and Uplisting to NYSE American Stock ExchangeNORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced the closing of its previously announced underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the “Securities”). Each share of common stock and accompanying warrant to purchase one share of common stock were sold together at a combined public offering price of $4.00. The warrants have an exercise price of $4.50 per share, are exercisable immediately and will expire five years from the issuance date. In addition, Reed’s granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock and/or 375,000 warrants at their respective public offering prices, less underwriting discounts and commissions.
Dyne Therapeutics Announces Proposed Public Offering of Common StockWALTHAM, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has commenced an underwritten public offering of $300,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a 30-day option to purchase up to an additional $45,000,000 of shares of its common stock. All of the shares in the proposed offering are to be sold by Dyne.
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common StockCAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that it has commenced an underwritten public offering of $150.0 million of shares of its common stock. Fulcrum also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock offered in the proposed public offering. All of the shares in the proposed offering are to be sold by Fulcrum.
Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded WarrantsSAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (
NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the commencement of a proposed underwritten public offering, subject to market and other conditions, to issue and sell $500 million of American depositary shares (ADSs), each representing three ordinary shares, or for certain investors that so choose, in lieu of ADSs, pre-funded warrants to purchase ordinary shares, represented by ADSs. All securities are being offered by Structure Therapeutics.
Vera Therapeutics Announces Proposed Public Offering of Class A Common StockBRISBANE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced its plans to commence a public offering, subject to market and other conditions, to issue and sell $200.0 million of shares of its Class A common stock. All of the shares are being offered by Vera Therapeutics.
Kite Realty Group Completes $474 Million in Dispositions and $86.1 Million of Additional Share RepurchasesINDIANAPOLIS, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group (
NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, today announced that the Company closed on the disposition of a portfolio that includes eight large-format power and community centers for gross proceeds of $429.0 million.
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsCAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), announced today that it has commenced an underwritten public offering of $250 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave intends to grant the underwriters a 30-day option to purchase ordinary shares in an amount up to an additional 15% of the total amount of ordinary shares and shares underlying pre-funded warrants sold in the public offering on the same terms and conditions. All of the securities in the offering will be sold by Wave Life Sciences.
Ascent Solar Technologies Announces Closing of Up to $5.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules$2 million upfront with up to approximately $3.5 million of potential aggregate proceeds upon the exercise in full of warrants
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar ChaudhuriWESTLAKE VILLAGE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Amit Munshi has been appointed to the Arcutis Board of Directors effective December 4, 2025, and announced the retirement of founder and long-serving Board member Bhaskar Chaudhuri, PhD. Dr. Chaudhuri will continue as a consultant for the Company.
Xtreme One Entertainment, Inc. (OTC: XONI) to Present at the Small Cap Growth Virtual Investor Conference on December 9Company invites individual and institutional investors, financial advisors, and analysts to attend online via VirtualInvestorConferences.com
DarkPulse, Inc. to Present at the Small Cap Growth Virtual Investor Conference December 9thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights.
Halper Sadeh LLC Encourages FRGE, TEX, REVG Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights.
FI Stockholders with Large Losses Should Reach Out to Robbins LLP to Learn About the Class Action Against Fiserv, Inc.SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Company: Fiserv, Inc. (
NASDAQ: FI) is a Milwaukee, Wisconsin-based global payments and financial technology provider.
HII Debuts GRIMM Spectrum Dominance Solution at AOC 2025 International Symposium & ConventionMcLEAN, Va., Dec. 08, 2025 (GLOBE NEWSWIRE) -- HII (
NYSE: HII) announced today that its Mission Technologies division has deployed and operationalized a next-generation high-performance spectrum dominance solution, now available for rapid detection and location of hostile communications, radar and other electronic threats.
OPESS AI Unveils New Daily Rewards Plan to Offer Stable Returns Amidst Market VolatilityOPESS AI combines innovation and convenience in a daily rewards plan, enabling users to make profits worry-free, anytime
Standard and Poor’s Revises Ballad Health Outlook to “Positive,” Affirming “A-” RatingDespite industry-wide pressures leading to credit downgrades outpacing upgrades, S&P’s positive revision cites Ballad Health’s experienced management team, execution of integration strategy, and quality improvement serving to “transform Ballad Health into a high-performing consolidated system”
Asymmetric Research and OtterSec Announce Shared Leadership to Meet Rising Blockchain Security DemandsNEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Asymmetric Research, a specialized security firm focused on long-term partnerships with L1s, L2s, and DeFi teams, and OtterSec, a technical audit company known for uncovering complex vulnerabilities, have formalized a shared leadership model that brings together two of the most technical teams in blockchain and web3 security. This move aligns leadership while preserving each team’s existing focus and operational track.
Halper Sadeh LLC Encourages AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights.
Halper Sadeh LLC Encourages CFLT, EB, RPTX Shareholders to Contact the Firm to Discuss Their RightsShareholders should contact the firm immediately as there may be limited time to enforce your rights.
Amplia Therapeutics Limited to Present at the Life Sciences Virtual Investor Forum December 11thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
IACMI: This machining training program has improved thousands of lives in 5 years. Make yours next.The national America’s Cutting Edge (ACE) program has helped manufacturing workers, students, teachers, and more gain in-demand skills to revitalize domestic manufacturing.
Echo IQ to Present at the Life Sciences Virtual Investor Forum on 11th DecemberCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Transaction in Own SharesTransaction in Own Shares
The Toy Association Shares the Top Holiday Toys of 2025 with YourUpdateTVToy Trends Specialist, Jennifer Lynch, Shares This Year’s Must-Have Picks, Highlighting Screen-Free Play, Immersive Toys, and Nostalgic, Feel-Good Favorites
Yamaha BLU CRU Racers Sweep 2025 Off-Road ChampionshipsYamaha Honors YFZ450R and YXZ1000R Racers at Annual Wall of Champions Celebration
Gainwell Technologies to Share Insights on Medicaid Modernization at CSG 2025Rushil Desai joins national leaders to discuss HR1, SNAP, and rural health innovation
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Confluent, Inc. (Nasdaq – CFLT), Eventbrite, Inc. (NYSE – EB), Crawford United Corporation (OTC – CRAWA), Mountain Commerce Bancorp, Inc. (OTC – MCBI)BALA CYNWYD, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)BALA CYNWYD, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the FirmNEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
FUN Investors Have Opportunity to Lead Six Flags Entertainment Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Six Flags Entertainment Corporation (“Six Flags” or “the Company”) (
NYSE: FUN) for violations of the federal securities laws.
Zoomex Launches “ZOOtopia Trading Festival” With a 30,000 USDT Airdrop and Exclusive Community RewardsDecember 2025 — Global cryptocurrency exchange Zoomex has officially launched the “ZOOtopia Trading Festival,” a platform-wide event combining meme-coin trading, daily missions, and exclusive community rewards. The campaign features a total prize pool of 30,000 USDT in airdrops, along with additional perks including fee rebates and movie-ticket giveaways.
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (
NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
International study offers new path to reduce spinal taps in young infants with feversNew evidence from a six-country study led by the Montreal Children’s Hospital and Children’s National Hospital shows simple blood and urine tests could spare many young infants with fevers from more invasive procedures.
Progressive Announces Dividend Information And 2026 Annual Meeting Record DateMAYFIELD VILLAGE, OHIO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- On December 5, 2025, the Board of Directors of The Progressive Corporation (
NYSE:PGR) declared an annual common share dividend, in the amount of $13.50 per share, and a quarterly common share dividend, in the amount of $0.10 per share.
KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (
NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Parsons Corporation Celebrates TraCSS Victory with Space News Icon Award for Civil Space Achievement of the YearCHANTILLY, Va., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (
NYSE:PSN), the systems integrator for the Office of Space Commerce’s (OSC) Traffic Coordination System for Space (TraCSS) program, is proud to announce that this groundbreaking advancement in space traffic coordination has been recognized with the esteemed 2025 SpaceNews Icon Award for Civil Space Achievement. This prestigious accolade underscores Parsons' commitment to advancing safe and efficient operations in an increasingly congested orbital environment.
South Florida Economic Development Organizations Visit New York City in Joint Effort to Strengthen Business Connections and Shared Economic TiesPalm Beach, Broward, and Miami-Dade Counties’ economic development leaders spotlight current connectivity and new cross-market opportunities between NYC and South Florida ‘Mega Region’
SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys” or “the Company”) (
NASDAQ: SNPS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Genshin Impact and Duolingo Team Up For a Learning Adventure in the Duolingo AppChallenge yourself in the limited-time Genshin Impact x Duolingo 3-Day Streak Quest in the Duolingo app — accompanied by Teyvat's best guide!
